Karnataka has launched India's first state-led Centre of Excellence for Space Technology (CoE SpaceTech Foundation) in Bengaluru. This init...

Biocon Biologics' drug substance facility in Bengaluru has been classified as Voluntary Action Indicated (VAI) by the USFDA. This classific...

Biocon Share Price: Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is...

Biocon Biologics' drug substance facility in Bengaluru has been classified by the USFDA as voluntary action indicated after a cGMP inspecti...

Biocon shares fell 2% to Rs 361.5 after the USFDA issued four observations following an inspection of its Bengaluru API facility. The compa...

Biocon Biologics received EMA approval to manufacture biosimilar Bevacizumab in Bengaluru, providing additional capacity to address patient...

US-based sciences company Cytiva has opened a new manufacturing facility and Experience Centre in Pune, India. The facility will double Cyt...

Strides Pharma Science has agreed to sell the biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma to Syngene ...

The CRL cites additional data required in the BLA submission and an expectation of satisfactory implementation of a corrective and preventi...

The USFDA conducted three on-site inspections of Biocon Biologics' seven manufacturing facilities spanning two sites in Bengaluru, India an...

The company's new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru has received the certif...

This additional approval of its new manufacturing facility for pegfilgrastim in Bengaluru will enable the biotechnology major to enable its...

Biopharma major Biocon reportedly received an Establishment Inspection Report (EIR) from US-FDA for its biologics drug product unit at Beng...

Biocon shares were trading 0.64 per cent higher that their previous close at Rs 226.85 on the BSE.

Biocon is confident of addressing these observations through a corrective and preventive action plan in a timely manner, it added.

Zumutor is in pre-phase one stage of developing a new version of a bestselling breast cancer drug with 20-fold functionality enhancement.

About 26% of the Biotech revenues of the country, particularly in terms of exports, are generated by the Biotech Industry in Karnataka, he ...